Literature DB >> 23692861

Angiotensin III: a physiological relevant peptide of the renin angiotensin system.

Vudhya G Yugandhar1, Michelle A Clark.   

Abstract

The renin angiotensin system (RAS) is a peptide hormone system that plays an important role in the pathophysiology of various diseases, including congestive heart failure, hypertension, myocardial infarction, and diabetic nephropathy. This has led researchers to focus extensively on this system, leading to the discovery of various peptides, peptidases, receptors and signal transduction mechanisms intrinsic to the RAS. Angiotensinogen (AGT), angiotensin (Ang) II, Ang III, Ang IV, and Ang-(1-7) are the main biologically active peptides of RAS. However, most of the available studies have focused on Ang II as the likely key peptide from the RAS that directly and indirectly regulates physiological functions leading to pathological conditions. However, data from recent studies suggest that Ang III may produce physiologically relevant effects that are similar to those produced by Ang II. Hence, this review focuses on Ang III and the myriad of physiological effects that it produces in the body.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aminopeptidase A; Angiotensin; Blood pressure; Cardiovascular; Renin angiotensin system; Sodium appetite; Vasopressin

Mesh:

Substances:

Year:  2013        PMID: 23692861     DOI: 10.1016/j.peptides.2013.04.014

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  29 in total

Review 1.  Astrocytes and the Renin Angiotensin System: Relevance in Disease Pathogenesis.

Authors:  Ann Tenneil O'Connor; Michelle A Clark
Journal:  Neurochem Res       Date:  2018-06-01       Impact factor: 3.996

Review 2.  The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.

Authors:  Xiao C Li; Jianfeng Zhang; Jia L Zhuo
Journal:  Pharmacol Res       Date:  2017-06-12       Impact factor: 7.658

3.  Molecular remodeling of the renin-angiotensin system after kidney transplantation.

Authors:  Marlies Antlanger; Oliver Domenig; Johannes J Kovarik; Christopher C Kaltenecker; Chantal Kopecky; Marko Poglitsch; Marcus D Säemann
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017 Apr-Jun       Impact factor: 1.636

Review 4.  Role of angiotensin modulation in primary headaches.

Authors:  Erling Tronvik; Lars Jacob Stovner
Journal:  Curr Pain Headache Rep       Date:  2014-05

Review 5.  The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications.

Authors:  Amanda J Miller; Amy C Arnold
Journal:  Clin Auton Res       Date:  2018-11-09       Impact factor: 4.435

Review 6.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 7.  Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathy.

Authors:  Mark T Waddingham; Amanda J Edgley; Hirotsugu Tsuchimochi; Darren J Kelly; Mikiyasu Shirai; James T Pearson
Journal:  World J Diabetes       Date:  2015-07-10

8.  A microanalytical capillary electrophoresis mass spectrometry assay for quantifying angiotensin peptides in the brain.

Authors:  Camille Lombard-Banek; Zhe Yu; Adam P Swiercz; Paul J Marvar; Peter Nemes
Journal:  Anal Bioanal Chem       Date:  2019-04-05       Impact factor: 4.142

9.  Poor Performance of Angiotensin II Enzyme-Linked Immuno-Sorbent Assays in Mostly Hypertensive Cohort Routinely Screened for Primary Aldosteronism.

Authors:  Agnieszka Łebek-Szatańska; Lucyna Papierska; Piotr Glinicki; Wojciech Zgliczyński
Journal:  Diagnostics (Basel)       Date:  2022-04-30

10.  Angiotensin III induces p38 Mitogen-activated protein kinase leading to proliferation of vascular smooth muscle cells.

Authors:  Ahmed Z Alanazi; Michelle A Clark
Journal:  Pharmacol Rep       Date:  2020-01-08       Impact factor: 3.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.